
|Slideshows|March 21, 2017
ACC 2017: CV Risk Factors
Author(s)Samantha J. Peterson
Research includes a possible link between Zika & CV issues, CV effects of cannabis use, and neurocognitive impairment with PCSK9 variants.
Advertisement
Presentations at the American College of Cardiology’s Annual Scientific Sessions included potential heart issues related to Zika infection, risk of stroke and heart failure with cannabis use, and neurocognitive impairment with PCSK9 variants.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
A Clinical Review of the 2025 Neuromyelitis Optica Spectrum Disorder Guidelines
2
Phase 2 Subpopulation Data of Vidofludimus Calcium in Progressive Multiple Sclerosis: Robert J. Fox, MD
3
FDA Action Update, December 2025: Acceptance, Approval, and Clearance
4
FDA Approves Generic Glatiramer Acetate Injection for Multiple Sclerosis Treatment
5



























